EDP-305

DRUG4 trials

Sponsors

Enanta Pharmaceuticals, Inc

Conditions

NASHNASH - Nonalcoholic Steatohepatitis

Phase 1

Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.

CompletedNCT03187496

Enanta Pharmaceuticals, IncNASH

Start: 2017-05-11End: 2017-06-14Updated: 2017-08-21

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

CompletedNCT03610945

Enanta Pharmaceuticals, IncNASH - Nonalcoholic Steatohepatitis

Start: 2018-07-19End: 2018-08-21Updated: 2018-12-05

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

CompletedNCT03748628

Enanta Pharmaceuticals, IncNASH - Nonalcoholic Steatohepatitis

Start: 2018-10-05End: 2018-10-13Updated: 2018-11-21

A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

CompletedNCT03783897

Enanta Pharmaceuticals, IncNASH - Nonalcoholic Steatohepatitis

Start: 2018-11-27End: 2019-06-18Updated: 2019-07-24